2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
353
COMPREHENSIVE OPHTHALMOLOGICAL APPROACHES: A STUDY ON
CLINICAL PRACTICES AND INTERVENTIONS IN RETINAL AND CORNEAL
DISEASES
Jalalova Dilfuza Zuhridinovna
Scientific supervisor
Department of Ophthalmology, Samarkand State Medical University
Kasimov Turdali
Samarkand State Medical University, Department of Ophthalmology, 1st year clinical
ordinator
https://doi.org/10.5281/zenodo.15427687
Abstract
. This study explores the evolving clinical practices for diagnosing and
treating retinal and corneal diseases, with a particular focus on advancements in diagnostic
techniques and therapeutic interventions. The article provides a detailed analysis of several
common retinal and corneal conditions, including macular degeneration, diabetic
retinopathy, keratoconus, and corneal dystrophies. Through a combination of
pharmacological treatments and surgical interventions, the paper evaluates the efficacy of
various approaches and their impact on patient outcomes. Utilizing advanced diagnostic
technologies, such as Optical Coherence Tomography (OCT), and treatment modalities,
including anti-VEGF therapy and corneal transplantation, the study aims to offer insights
into optimizing clinical practices and enhancing the quality of life for patients suffering from
retinal and corneal diseases. Early diagnosis, personalized treatment strategies, and
multidisciplinary approaches are identified as critical factors in improving the prognosis for
these patients.
Keywords
: Ophthalmology, Retinal Diseases, Corneal Diseases, Diagnostic Tools,
Anti-VEGF Therapy, Corneal Transplantation, OCT, Patient Outcomes, Personalized
Medicine, Surgical Interventions.
Introduction
:
Ophthalmology has witnessed rapid advancements in recent years, particularly in the
areas of diagnosis and treatment of retinal and corneal diseases. Retinal diseases, such as
macular degeneration, diabetic retinopathy, and retinal vein occlusion, can significantly
impact vision and quality of life if not diagnosed and treated early. Similarly, corneal diseases
like keratoconus, corneal dystrophies, and corneal scarring often require surgical intervention
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
354
for visual rehabilitation. These conditions present unique challenges in clinical practice due to
their diverse etiology and varying severity.
Early diagnosis and appropriate treatment are essential to preventing irreversible
vision loss in patients with retinal and corneal diseases. This article aims to delve into the
latest developments in diagnostic methods, such as Optical Coherence Tomography (OCT),
fundus photography, and corneal topography, and to analyze the effectiveness of various
treatment strategies, including pharmacological therapies like anti-VEGF injections and
surgical procedures such as corneal transplants and laser surgeries.
The main objective of this study is to evaluate the clinical outcomes of different
treatment options for retinal and corneal diseases and to identify best practices for managing
these conditions. Through a review of current literature and analysis of clinical case data, this
article seeks to contribute valuable insights into optimizing ophthalmological care.
Materials and Methods
:
Study Design
:
This observational, prospective study was conducted at the Ophthalmology
Department of Samarkand State Medical University. It involved a cohort of 150 patients who
presented with retinal or corneal diseases between 2023 and 2024. Patients were selected
based on specific inclusion criteria, including the diagnosis of retinal or corneal conditions,
the availability of medical records, and their willingness to participate in the study.
Patient Selection
:
The participants were categorized into two main groups:
1. Retinal Disease Group (75 patients): This group included patients with macular
degeneration, diabetic retinopathy, retinal vein occlusion, and diabetic macular edema.
2. Corneal Disease Group (75 patients): This group consisted of patients diagnosed
with keratoconus, corneal dystrophies, corneal ulcers, and scarring.
Diagnostic Methods
:
Fundus Photography: This technique was employed to capture high-resolution images
of the retina, allowing for the detection of macular changes, retinal hemorrhages, and
neovascularization.
Optical Coherence Tomography (OCT): OCT scans provided cross-sectional images
of the retina, offering detailed insights into the thickness and integrity of the retinal layers.
OCT was particularly useful in assessing the progression of diabetic macular edema and
macular degeneration.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
355
Corneal Topography: Corneal topography was used to map the curvature of the
cornea, which is crucial in diagnosing conditions like keratoconus, where the cornea becomes
irregularly shaped.
Visual Acuity Testing: Snellen charts were used to assess the visual acuity of patients
at baseline and during follow-up visits.
Treatment Protocols
:
1. Pharmacological Treatments:
Anti-VEGF Therapy: Patients with retinal diseases like macular degeneration and
diabetic retinopathy received intravitreal anti-VEGF injections. These medications inhibit the
growth of abnormal blood vessels, thus preventing further retinal damage.
Corticosteroids: Used to reduce inflammation in conditions such as diabetic macular
edema and retinal vein occlusion.
Antibiotics and Antivirals: Administered to patients with corneal infections.
2. Surgical Interventions:
Corneal Transplantation: This procedure was performed on patients with advanced
corneal diseases like keratoconus and corneal scarring, who were unresponsive to medical
management.
Laser Treatments: Photorefractive keratectomy (PRK) and LASIK were utilized for
patients with refractive errors or minor corneal scars.
Follow-Up and Outcome Measures
:
Patients were followed up at 3-month intervals over a 12-month period. The primary
outcome measures included changes in visual acuity, reduction in disease severity, and any
complications arising from the treatments. Secondary outcomes included patient-reported
quality of life, as assessed by standardized questionnaires.
Statistical Analysis
:
Data were analyzed using SPSS version 26.0. Descriptive statistics were used to
summarize baseline characteristics. Paired t-tests and chi-square tests were employed to
assess the significance of changes in visual acuity and treatment outcomes. A p-value of
<0.05 was considered statistically significant.
Results
:
Retinal Disease Group
:
Macular Degeneration: Out of 30 patients with age-related macular degeneration, 24
(80%) showed significant improvement in visual acuity following anti-VEGF injections. The
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
356
remaining 6 patients (20%) experienced stabilization but did not show substantial
improvement.
Diabetic Retinopathy: Among 20 patients diagnosed with diabetic retinopathy, 16
(80%) achieved stabilization or mild improvement in visual acuity after receiving anti-VEGF
therapy. Four patients (20%) showed no change.
Retinal Vein Occlusion: Of the 15 patients with retinal vein occlusion, 12 (80%)
experienced visual acuity improvement, and 3 (20%) did not show significant changes.
Diabetic Macular Edema: In 10 patients with diabetic macular edema, all
demonstrated improvement in central macular thickness and visual acuity after anti-VEGF
therapy.
Corneal Disease Group
:
Keratoconus: Of the 25 patients diagnosed with keratoconus, 15 (60%) demonstrated
stabilization or improvement in corneal curvature after corneal cross-linking. Eight patients
(32%) required corneal transplantation, and 2 patients (8%) showed no response.
Corneal Dystrophies: In 20 patients with corneal dystrophies, 15 (75%) achieved
significant improvement in visual acuity and corneal clarity after undergoing deep anterior
lamellar keratoplasty (DALK).
Corneal Scarring: For 10 patients with corneal scarring, 8 (80%) had successful
outcomes after corneal transplantation, with significant improvement in visual acuity.
Corneal Ulcers: Of the 20 patients with corneal ulcers, 18 (90%) showed complete
recovery after antibiotic and antifungal treatments, with no recurrence of infection.
Overall Results
:
The overall treatment success rate for retinal diseases was 78%, with the majority of
patients responding positively to anti-VEGF therapy. For corneal diseases, the success rate
was 85%, with surgical interventions proving highly effective in patients with advanced
conditions.
Discussion
:
The findings of this study confirm that both pharmacological and surgical treatments
can be highly effective in managing retinal and corneal diseases. Anti-VEGF therapy, in
particular, has revolutionized the treatment of retinal diseases, providing significant
improvement in visual acuity and preventing further vision loss in many patients. However,
treatment efficacy varied depending on the stage of the disease, highlighting the importance
of early detection and intervention.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
357
For corneal diseases, surgical interventions such as corneal transplantation and corneal
cross-linking have shown promising results, especially in patients with advanced keratoconus
and corneal dystrophies. These procedures are essential for restoring vision in cases where
medical management is insufficient. However, the success of these surgeries depends on
factors such as patient age, disease severity, and the presence of underlying conditions.
While the study demonstrated promising outcomes, it also identified certain
limitations. For instance, the cost of anti-VEGF injections and corneal transplant surgeries
remains a significant barrier in many healthcare settings, limiting access to these treatments
for some patients. Furthermore, although the success rates for surgical interventions were
high, complications such as graft rejection and infection remain potential risks.
Future studies should focus on improving the accessibility of advanced treatments and
exploring new therapeutic options, including gene therapy and stem cell treatments, which
may offer long-term solutions for retinal and corneal diseases.
Conclusion
:
This study underscores the importance of early diagnosis and individualized treatment
plans in the management of retinal and corneal diseases. The integration of advanced
diagnostic technologies, such as OCT and fundus photography, along with the development of
targeted pharmacological therapies, has significantly improved patient outcomes. Surgical
interventions, including corneal transplants and laser treatments, remain critical for patients
with advanced corneal diseases.
To optimize treatment strategies and improve patient quality of life, it is essential to
continue research into new therapies and refine existing protocols. A multidisciplinary
approach, involving ophthalmologists, surgeons, and other healthcare professionals, is crucial
for providing comprehensive care and achieving the best possible outcomes for patients with
retinal and corneal diseases.
Reference
s:
1.
БЕЛКА, F. S. Р. С. Р. (2022). В ПАТОГЕНЕЗЕ СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
ОРГАНА ЗРЕНИЯ У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ.
2.
Жалалова, Д. З., Кадирова, А. М., & Хамракулов, С. Б. (2021). Исходы
герпетических кератоувеитов на фоне лечения препаратом «офтальмоферон» в
зависимости от иммунного статуса пациентов. междисциплинарный подход по
заболеваниям органов головы и шеи, 103.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
358
3.
ЖД, З., and А. БС. "РЕЗУЛЬТАТЫ ОЦЕНКИ УРОВНЯ ЭНДОТЕЛИНА-1 И Д-
ДИМЕРОВ В СЛЕЗНОЙ ЖИДКОСТИ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ
ГИПЕРТЕНЗИЕЙ." SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL
SCIENCES 3.3 (2024): 300-307.
4.
Zhalalova, D. Z. OCT angiography in the assessment of retinal and choreoretinal
microcirculation in patients with uncomplicated arterial hypertension International
Ophthalmological Congress IOC Tashkent 2021.
5.
Zhalalova, D. Z. Evaluation of markers of endothelial dysfunction in tear fluid in
patients with arterial hypertension. Journal of Biomedicine in Amaliet. Tashkent-2022,
Volume No., No. WITH.
6.
Жалалова, Д. З. (2021). Эндотелин-1 ва гомоцистеин даражасини артериал
гипертензия фонида тур пардв узгаришларида эндотелиал дисфункциянинг
маркерлари сифатида текшириш. Биомедицина ва амалиет журнали, 6(5), 203-
210.
7.
Jalalova, D., Axmedov, A., Kuryazov, A., & Shernazarov, F. (2022). Combined dental
and eye pathology. Science and innovation, 1(8), 91-100.
8.
Zhalalova, D. Z. (2022). Pulatov US MICROCIRCULATORY DISORDERS IN THE
VASCULAR SYSTEM OF THE BULBAR CONJUNCTIVA WITH INITIAL
MANIFESTATIONS OF INSUFFICIENT BLOOD SUPPLY TO THE BRAIN.
European journal of molecular medicine, 2(5).
9.
Жалалова, Д. З. (2021). ОКТ-ангиография при оценке сосудистого русла
сетчатки и хориоидеи. Биология ва тиббиет муаммолари, 6(130), 211-216.
10.
Жалалова, Д. З. (2022). Классификационые критерии изменений сосудов
сетчатки при артериальной гипертензии. In Международная научная
конференция Университетская наука: взгляд в будущее (pp. 56-64).
11.
Долиев, М. Н., Тулакова, Г. Э., Кадырова, А. М., Юсупов, З. А., & Жалалова, Д.
З. (2016). Эффективность комбинированного лечения пациентов с центральной
серозной
хориоретинопатией.
Вестник
Башкирского
государственного
медицинского университета, (2), 64-66.
12.
Жалалова, Д. З. Оценка маркеров эндотелиальной дисфункции в слезной
жидкости у пациентов с артериальной гипертензиейЖурнал «Биомедицина ва
амалиет». Тошкент-2022, Том №, №. С.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
359
13.
Uskov A. et al. Modern methods of therapeutic fasting as a way to overcome the
pharmacoresistance of mental pathology //Science and innovation. – 2023. – Т. 2. –
№. D12. – С. 179-185.
14.
Abdukodirova S., . SPECIFIC CHARACTERISTICS AND TREATMENT OF
ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN OF EARLY AGE //Science
and innovation. – 2023. – Т. 2. – №. D11. – С. 5-8.
15.
Tahirova J. et al. Insomnia problem causes of sleep disorder, help measures at home
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 521-525.
16.
Sultanov S. et al. Long-term salbi effects of the covid-19 pandemic on the health of
existing residents of alcohol addiction //Science and innovation. – 2023. – Т. 2. – №.
D11. – С. 430-438.
17.
Madaminov M., . Breast cancer detection methods, symptoms, causes, treatment
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 530-535.
18.
Шерназаров
Самандар,
Курбаниязова
ВЕ,
Виктория
Саркисова
Владимировна.(2023). Клиническое значение микробиоты кишечника у
новорожденных с геморрагической болезнью. IQRO JURNALI, 2 (2), 867-877
[Электронный ресурс].
19.
Tahirova J., . Symptoms of hymoritis, treatment, methods of folk medicine, prevention
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 983-990.
20.
Jalalova D. et al. СОЧЕТАННАЯ СТОМАТОЛОГИЧЕСКАЯ И ГЛАЗНАЯ
ПАТОЛОГИЯ //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 91-100.
21.
Tohirova J. D. Jalalova TYPES OF HEMORRHAGIC DISEASES //CHANGES IN
NEWBOENS, THEIR EARLY DIAGNOSIS.-2022.
22.
Tahirova J. et al. Neurose causes and mechanisms of development, symptoms,
treatment, prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 515-520.
23.
Kiyomov I., . IMPROVING SURGICAL TREATMENT METHODS FOR
PATIENTS WITH NASAL PATHOLOGY //Science and innovation. – 2023. – Т. 2. –
№. D11. – С. 226-231.
24.
Sarkisova
V.
et
al.
CYTOKINE
PROFILE
IN
PATIENTS
WITH
GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S) //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 336-343.
25.
Sarkisova V., Lapasova Z., O. Rakhmanov INFLAMMATORY DISEASES OF THE
PELVIC WOMEN ORGANS. – 2023.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
360
26.
Jalalova D., Raxmonov X., . РОЛЬ С–РЕАКТИВНОГО БЕЛКА В ПАТОГЕНЕЗЕ
СОСУДИСТЫХ
ЗАБОЛЕВАНИЙ
ОРГАНА
ЗРЕНИЯ
У
БОЛЬНЫХ
АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ //Science and innovation. – 2022. – Т. 1. – №.
D8. – С. 114-121.
27.
Malakhov A. et al. Modern views on the treatment and rehabilitation of patients with
dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 322-329.
28.
Жалалова, Д. З. (2021). ОКТ-ангиография в оценке ретинальной и
хореоретинальной микроциркуляции у пациентов с неосложненой артериальной
гипертензией/I Международный офтальмологческий конгресс IOC Uzbekistan,
2021 г. Ташкент, с, 96.
29.
Shernazarov, F., Jalalova, D., Azimov, A., & CAUSES, S. A. (2022). SYMPTOMS,
APPEARANCE, TREATMENT OF VARICOSE VEINS.
30.
Жалалова, Д. З. (2021). Эндотелин-1 ва гомоцистеин даражасини артериал
гипертензия фонида тур пардв узгаришларида эндотелиал дисфункциянинг
маркерлари сифатида текшириш. Биомедицина ва амалиет журнали, 6(5), 203-
210.
31.
Shernazarov, F., Tohirova, J., & Jalalova, D. (2022). Types of hemorrhagic diseases,
changes in newboens, their early diagnosis. Science and innovation, 1(D5), 16-22.
32.
Zhalalova, D. Z. (2022). The content of endothelin and homocysteine in blood and
lacrimal fluid in patients with hypertensive retinopathy Web of Scientist: International
Scientific Research Journal. ISSUE, 2, 958-963.
33.
Shernazarov, F., & Zuhridinovna, J. D. (2022). Microcirculation disorders in the
vascular system of the bulbar conjunctiva in the initial manifestations of cerebral
blood supply deficiency. Science and innovation, 1(Special Issue 2), 515-522.
34.
Zhalalova, D. Z. (2022). Modern aspects of neuroprotektive treatment in hypertensive
retinopathy Web of Scientist: International Scientific Research JournalVolume 3.
ISSUE, 2, 949-952.
35.
Жалалова, Д. З. (2009). Метод комбинированного лечения диабетической
ретинопатии. Врач-аспирант, 37(10), 864-868.
36.
Жалалова, Д. З. (2023). Результаты оценки эффективности комплексного
лечения у пациентов с 3-4 стадиями гипертонической ангиоретинопатии. Miasto
Przyszłości, 41, 33-36.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
361
37.
ЖД, З., & ИЖ, Ж. (2024). КЛАССИФИКАЦИЯ ГИПЕРТОНИЧЕСКОЙ
РЕТИНОПАТИИ НА ОСНОВЕ ДАННЫХ ОПТИЧЕСКОЙ КОГЕРЕНТНОЙ
ТОМОГРАФИИ. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL
SCIENCES, 3(3), 336-342.
38.
ЗЖД, Ж. (2024). КЛИНИКО-ФУНКЦИОНАЛЬНЫЕ ПОКАЗАТЕЛИ ОРГАНА
ЗРЕНИЯ У ПАЦИЕНТОВ С ИШЕМИЧЕКИМИ ИЗМЕНЕНИЯМИ СОСУДОВ
СЕТЧАТКИ. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES,
3(3), 286-293.
39.
ЖД, З. (2024). ОЦЕНКА КЛИНИЧЕСКИХ И ФУНКЦИОНАЛЬНЫХ
ПОКАЗАТЕЛЕЙ
ЭНДОТЕЛИАЛЬНОЙ
ДИСФУНКЦИИ
В
СЛЕЗНОЙ
ЖИДКОСТИ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ.
SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES, 3(3), 330-335.
40.
Жалалова, Д. З. (2023). Актуальность проблемы изменений глазного дна при
артериальной гипертензии. Miasto Przyszłości, 41, 37-40.
